News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK): No Tax Inversions, We Just Want Bolt-On Deals


7/30/2014 6:34:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Unlike some other drug makers, Merck is fine with its tax rate just where it is.

On an earnings call with analysts Tuesday morning, Merck executives dismissed any thought that it would follow other drug makers and seek a deal overseas to lower its tax rate. Based in Whitehouse Station, N.J., Merck currently pays taxes at a rate between 24% and 26%.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES